-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Medpace Holdings, Lowers Price Target to $484

Benzinga·04/24/2026 13:59:13
Listen to the news
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.